Scott Requadt - Insider Trading & Ownership

Entity
Individual
Location
101 Main Street, Suite 1210, Cambridge, MA
Summary
The estimated net worth of Scott Requadt is at least $17.8M dollars as of March 28, 2024. Scott Requadt is the Former Chief Executive Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $17.5M. Scott Requadt is the Director of ESSA Pharma Inc. and owns shares of ESSA Pharma Inc. (EPIX) stock worth about $300K.
All Insider Reports
All Insider Reports

Ownership of Scott Requadt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. Former Chief Executive Officer $17.5M Jul 3, 2023
EPIX ESSA Pharma Inc. Director $300K Mar 25, 2024

Insider Transactions Reported by Scott Requadt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.